BlueSky Immunotherapies
Austria - ViennaBiotechnology
Focus: BlueSky Immunotherapies is an Austrian biotech focused on virotherapy for cancer, specifically leveraging oncolytic viruses to treat HPV-driven malignancies. The company operates as a pre-revenue biotech with a highly specialized therapeutic approach.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About BlueSky Immunotherapies
AI assessmentNot HiringNo open roles listed right now. Follow BlueSky Immunotherapies to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Observation without intervention
Safety IssuesClinical Trials (1)
NCT04528407BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects
N/AHelp build intelligence for BlueSky Immunotherapies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.